TWO-STAGE FACE TRANSPLANTATION: A NEW CONCEPT IN VASCULARIZED COMPOSITE ALLOTRANSPLANTATION

被引:3
|
作者
Ramirez, Alejandro E. [1 ,2 ]
Lao, William W. [1 ,3 ]
Wang, Yen-Ling [4 ]
Cheng, Hui-Yun [4 ]
Wei, Fu-Chan [4 ,5 ,6 ]
机构
[1] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Microsurg, Taoyuan, Taiwan
[2] Pontificia Univ Catolica Chile, Dept Plast & Reconstruct Surg, Santiago, Chile
[3] Med Coll Wisconsin, Dept Plast & Reconstruct Surg, Milwaukee, WI 53226 USA
[4] Chang Gung Mem Hosp, Ctr Vascularized Composite Allotransplantat, Taoyuan, Taiwan
[5] Chang Gung Univ, Sch Med, Taoyuan, Taiwan
[6] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan
关键词
TISSUE ALLOTRANSPLANTATION; ALLOGRAFT TRANSPLANTATION; FACIAL TRANSPLANTATION; ECTOPIC IMPLANTATION; MODEL; RATS; REJECTION; HISTORY; FUTURE; SWINE;
D O I
10.1002/micr.22338
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Animal models and clinical cases of facial allotransplantation have been performed as a single stage procedure. A staged surgery might offer some advantages in selected cases. In this study, a two-stage face transplantation approach was performed on rat and the feasibility and safety were evaluated. Methods: Brown Norway rats were used as donors and Lewis rats as recipients in the allotransplantation groups. A total of 33 hemiface-scalp transplantations were performed. Syngeneic orthotopic transplantations were performed either in one-stage (one single stage surgery; N=3), local two-stage [heterothopic transplantation to the neck during the first stage and graft rotation as a pedicled flap to cover the facial defect on postoperative day (POD) 2; N=3], or distant two-stage approaches (heterothopic transplantation to the groin during the first stage and free graft transfer to the face on postoperative day 2; N=3). In the allotransplantation groups using the same approaches, 12 received no treatment (N=4 each subgroup) and 12 received the same tapering dose of cyclosporine (10 to 2 mg/Kg/day; N=4 each subgroup). Graft survival and the rejection grades were assessed clinically and pathologically. Results: All syngeneic transplants survived for the follow-up period of 180 days. The mean rejection-free survival and total survival of the allograft in the no treatment group was 6 +/- 0.3 and 14.3 +/- 4.5 days in the one-stage group, 6 +/- 0.4 and 18.5 +/- 1 days in the local two-stage group and 6 +/- 0.2 and 14.3 +/- 5.7 (P>0.05). All allografts in the treatment groups did not develop rejection during the 42 days follow-up period. Conclusions: It is feasible, reliable, reproducible, and safe to perform a two-stage face transplantation in rats. This novel approach has the potential to be applied in research and eventually in selected clinical cases of facial allotransplantation. (c) 2014 Wiley Periodicals, Inc. Microsurgery 35:218-226, 2015.
引用
收藏
页码:218 / 226
页数:9
相关论文
共 50 条
  • [41] Two-stage Cascade Model for Unconstrained Face Detection
    Marcetic, Darijan
    Hrkac, Tomislav
    Ribaric, Slobodan
    2016 FIRST INTERNATIONAL WORKSHOP ON SENSING, PROCESSING AND LEARNING FOR INTELLIGENT MACHINES (SPLINE), 2016,
  • [42] A two-stage approach to automatic-face alignment
    Wang, T
    Ai, HZ
    Huang, GF
    THIRD INTERNATIONAL SYMPOSIUM ON MULTISPECTRAL IMAGE PROCESSING AND PATTERN RECOGNITION, PTS 1 AND 2, 2003, 5286 : 558 - 563
  • [43] SSFD+: A robust two-stage face detector
    Shi L.
    Xu X.
    Kakadiaris I.A.
    IEEE Transactions on Biometrics, Behavior, and Identity Science, 2019, 1 (03): : 181 - 191
  • [44] New Paradigms in Rejection Monitoring: Lymphocyte Subsets as Noninvasive Graft Markers in Vascularized Composite Allotransplantation
    Chinta, Sachin R.
    Shah, Alay R.
    Tran, David L.
    Lee, Wen-Yu
    Mangiola, Massimo
    Gelb, Bruce E.
    Ceradini, Daniel J.
    Rodriguez, Eduardo D.
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2025, 13 (03)
  • [45] Ethical challenges in vascularized composite allotransplantation of the lower extremity: lessons learned from hand transplantation and implications for the future
    Xu, Amy L.
    Humbyrd, Casey Jo
    PLASTIC AND AESTHETIC RESEARCH, 2022, 9
  • [46] Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation
    Wang, Howard D.
    Fidder, Samuel A. J.
    Miller, Devin T.
    Furtmueller, Georg J.
    Ahmadi, Ali R.
    Nagele, Felix
    Lopez, Joseph
    Quan, Amy
    Budihardjo, Joshua
    Lough, Denver M.
    Akpinarli, Burcu
    Etra, Joanna W.
    Vasilic, Dalibor
    Raimondi, Giorgio
    Lee, W. P. Andrew
    Montgomery, Robert A.
    Sun, Zhaoli
    Brandacher, Gerald
    TRANSPLANTATION, 2018, 102 (04) : 593 - 600
  • [47] POST TRANSPLANTATION HIGH-DOSE CYCLOPHOSPHAMIDE TREATMENT TO PROMOTE IMMUNE TOLERANCE AFTER VASCULARIZED COMPOSITE ALLOTRANSPLANTATION
    Furtmueller, Georg
    Fryer, Madeline
    Oh, Byoungchol
    Ganguly, Sudipto
    Dodd-O, Jeffrey
    Raimondi, Giorgio
    Lee, Wp Andrew
    Luznik, Leo
    Brandacher, Gerald
    TRANSPLANT INTERNATIONAL, 2015, 28 : 80 - 80
  • [48] Technical, Immunological, and Ethical Similarities and Differences Between Vascularized Composite Allotransplantation and Solid Organ Transplantation in Current Practice
    Ozkan, O.
    Ertosun, M. Gokhan
    Ozkan, O.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) : 3775 - 3782
  • [49] Innovative Two-Stage Multibeam Klystron: Concept and Modeling
    Teryaev, Vladimir E.
    Shchelkunov, Sergey, V
    Hirshfield, Jay L.
    IEEE TRANSACTIONS ON ELECTRON DEVICES, 2020, 67 (07) : 2896 - 2899
  • [50] A Lifesaving View of Vascularized Composite Allotransplantation: Patient Experience of Social Death Before and After Face, Hand, and Larynx Transplant
    Bramstedt, Katrina A.
    JOURNAL OF PATIENT EXPERIENCE, 2018, 5 (02): : 92 - 100